Breast Cancer

Papers
(The TQCC of Breast Cancer is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
The frequency of low HER2 expression in breast cancer and a comparison of prognosis between patients with HER2-low and HER2-negative breast cancer by HR status109
Prognostic significance and targeting tumor-associated macrophages in cancer: new insights and future perspectives64
A machine learning-based radiomics model for the prediction of axillary lymph-node metastasis in breast cancer55
Impact of exercise interventions on physical fitness in breast cancer patients and survivors: a systematic review40
Friend or foe: ABCG2, ABCC1 and ABCB1 expression in triple-negative breast cancer35
Prognostic value of tumor-infiltrating B lymphocytes and plasma cells in triple-negative breast cancer35
Prognostic values of clinical and molecular features in HER2 low-breast cancer with hormonal receptor overexpression: features of HER2-low breast cancer35
Effects of yoga on improving quality of life in patients with breast cancer: a meta-analysis of randomized controlled trials34
Axillary surgery for breast cancer: past, present, and future32
Associations of adiposity and weight change with recurrence and survival in breast cancer patients: a systematic review and meta-analysis31
Inhibition of Cdc20 suppresses the metastasis in triple negative breast cancer (TNBC)31
Human umbilical cord mesenchymal stem cell-derived exosomes inhibit migration and invasion of breast cancer cells via miR-21-5p/ZNF367 pathway29
A systematic review of behaviour change techniques used in interventions to increase physical activity among breast cancer survivors27
Overexpression of SERPINA3 promotes tumor invasion and migration, epithelial-mesenchymal-transition in triple-negative breast cancer cells26
Immune-related biomarkers in triple-negative breast cancer25
CD1a- and CD83-positive dendritic cells as prognostic markers of metastasis development in early breast cancer patients24
Effect of Apatinib plus melatonin on vasculogenic mimicry formation by cancer stem cells from breast cancer cell line23
Negative impact of the COVID-19 state of emergency on breast cancer screening participation in Japan22
Overall assessment system of combined mammography and ultrasound for breast cancer screening in Japan22
Impact of body mass index on pathological complete response following neoadjuvant chemotherapy in operable breast cancer: a meta-analysis21
PI3K/AKT and MAPK1 molecular changes preceding matrix metallopeptidases overexpression during tamoxifen-resistance development are correlated to poor prognosis in breast cancer patients19
The potential role of nicotine in breast cancer initiation, development, angiogenesis, invasion, metastasis, and resistance to therapy19
Characteristics of female breast cancer in japan: annual report of the National Clinical Database in 201818
Discriminating low-grade ductal carcinoma in situ (DCIS) from non-low-grade DCIS or DCIS upgraded to invasive carcinoma: effective texture features on ultrafast dynamic contrast-enhanced magnetic reso17
The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2022 edition16
Loco-regional therapy and the risk of breast cancer-related lymphedema: a systematic review and meta-analysis16
Impact of artificial intelligence in breast cancer screening with mammography16
Racial and socioeconomic inequities in breast cancer screening before and during the COVID-19 pandemic: analysis of two cohorts of women 50 years +15
Identification of key tumor stroma-associated transcriptional signatures correlated with survival prognosis and tumor progression in breast cancer15
Effects of a personal trainer-led exercise intervention on physical activity, physical function, and quality of life of breast cancer survivors15
Japanese subgroup analysis of the phase 3 MONARCH 3 study of abemaciclib as initial therapy for patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced brea15
Obesity-related protein biomarkers for predicting breast cancer risk: an overview of systematic reviews15
Microsurgical techniques in the treatment of breast cancer-related lymphedema: a systematic review of efficacy and patient outcomes14
Japanese subpopulation analysis of MONARCH 2: phase 3 study of abemaciclib plus fulvestrant for treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer 14
Association between dietary phytochemical index and breast cancer: a case–control study14
LncRNA SNHG5 promotes the glycolysis and proliferation of breast cancer cell through regulating BACH1 via targeting miR-29913
Quercetin: a silent retarder of fatty acid oxidation in breast cancer metastasis through steering of mitochondrial CPT113
Characteristics of interstitial lung disease in patients from post-marketing data on metastatic breast cancer patients who received abemaciclib in Japan12
Clinicopathological predictors of postoperative upstaging to invasive ductal carcinoma (IDC) in patients preoperatively diagnosed with ductal carcinoma in situ (DCIS): a multi-institutional retrospect12
Clinical effects of assessing electronic patient-reported outcomes monitoring symptomatic toxicities during breast cancer therapy: a nationwide and population-based study11
The transverse musculocutaneous gracilis flap for autologous breast reconstruction: focus on donor site morbidity11
Isoforms of IDH in breast carcinoma: IDH2 as a potent prognostic factor associated with proliferation in estrogen-receptor positive cases11
Podoplanin expression in cancer-associated fibroblasts predicts unfavorable prognosis in node-negative breast cancer patients with hormone receptor-positive/HER2 − negative subtype11
Sexuality in breast cancer survivors: sexual experiences, emotions, and cognitions in a group of women under hormonal therapy10
Accuracy of morphologic change measurements by ultrasound in predicting pathological response to neoadjuvant chemotherapy in triple-negative and HER2-positive breast cancer10
Long-term outcomes of oligometastatic breast cancer patients treated with curative intent: an updated report10
The safety of performing breast reconstruction during the COVID-19 pandemic10
Nationwide mammographic screening and breast cancer mortality in Taiwan: an interrupted time-series analysis10
Impact of obesity on clinical outcomes in hormone receptor-positive breast cancer: a systematic review10
Clinicopathological characteristics, practical treatments, prognosis, and clinical issues of older breast cancer patients in Japan10
Perceived physical fatigability improves after an exercise intervention among breast cancer survivors: a randomized clinical trial9
Clinical benefit of treatment after trastuzumab emtansine for HER2-positive metastatic breast cancer: a real-world multi-centre cohort study in Japan (WJOG12519B)9
Clinicopathological features of male patients with breast cancer based on a nationwide registry database in Japan9
Alteration of Trop-2 expression in breast cancer cells by clinically used therapeutic agents and acquired tamoxifen resistance9
Surgical treatment trends and identification of primary breast tumors after surgery in occult breast cancer: a study based on the Japanese National Clinical Database—Breast Cancer Registry9
HER2-low-positive and response to NACT and prognosis in HER2-negative non-metastatic BC9
Prognostic model based on six PD-1 expression and immune infiltration-associated genes predicts survival in breast cancer9
Initial experience with targeted axillary dissection after neoadjuvant therapy in breast cancer patients9
The associations of healthy lifestyle index with breast cancer incidence and mortality in a population-based study9
Subcellular localization of EZH2 phosphorylated at T367 stratifies metaplastic breast carcinoma subtypes8
PAM50- and immunohistochemistry-based subtypes of breast cancer and their relationship with breast cancer mortality in a population-based study8
Assessment of integrative non-pharmacological interventions and quality of life in breast cancer patients using real-world data8
Psychometric properties of the SF-6Dv2 in an Iranian breast cancer population8
Sensitivity and specificity of screening mammography without clinical breast examination among Japanese women aged 40–49 years: analysis of data from the J-START results8
Indices of peripheral leukocytes predict longer overall survival in breast cancer patients on eribulin in Japan8
Discovery and function exploration of microRNA-155 as a molecular biomarker for early detection of breast cancer8
Use and impact of breast cancer survivorship care plans: a systematic review8
Association of lymphatic flow velocity with surgical outcomes in patients undergoing lymphovenous anastomosis for breast cancer-related lymphedema8
TP53 signature diagnostic system using multiplex reverse transcription–polymerase chain reaction system enables prediction of prognosis of breast cancer patients8
Breast-conserving therapy for breast cancer with BRCA mutations: a meta-analysis8
Optimal duration of endocrine therapy with extended aromatase inhibitors for postmenopausal patients with hormone receptor-positive breast cancer: a meta-analysis8
LncRNA FOXD3-AS1 promotes breast cancer progression by mediating ARF68
Diagnostic performance of dedicated breast positron emission tomography8
A novel immune-related prognostic index for predicting breast cancer overall survival7
Effect of patient decision aids on decisional conflict and regret associated with breast cancer surgery: a randomized controlled trial7
The effectiveness of moisturizer on acute radiation-induced dermatitis in breast cancer patients: a systematic review and meta-analysis7
Dynamic changes in quality of life, psychological status, and body image in women who underwent a mastectomy as compared with breast reconstruction: an 8-year follow up7
Differential expression of the BCAT isoforms between breast cancer subtypes7
PIK3CA somatic alterations in invasive breast cancers: different spectrum from Caucasians to Chinese detected by next generation sequencing7
A transposon screen identifies enhancement of NF-κB pathway as a mechanism of resistance to eribulin7
A history of severe nausea and vomiting during pregnancy predicts a higher incidence of postoperative nausea and vomiting after breast cancer surgery without breast reconstruction7
Internal mammary lymph node metastasis in breast cancer patients based on anatomical imaging and functional imaging7
Understanding breast cancer heterogeneity through non-genetic heterogeneity7
Role of dietary fat on obesity-related postmenopausal breast cancer: insights from mouse models and methodological considerations6
High chromosome instability identified by low-pass whole-genome sequencing assay is associated with TP53 copy loss and worse prognosis in BRCA1 germline mutation breast cancer6
Breast implant associated anaplastic large cell lymphoma (BIA-ALCL): a challenging cytological diagnosis with hybrid PET/MRI staging and follow-up6
Comparison of thoracic and abdominal deep inspiration breath holds in whole-breast irradiation for patients with left-sided breast cancer6
ER–/PR+ breast cancer is controlled more effectively with an inflammatory inhibitor than hormonal inhibitor6
Usefulness of new shear wave elastography in early predicting the efficacy of neoadjuvant chemotherapy for patients with breast cancer: where and when to measure is optimal?6
Adenosquamous carcinoma of the breast: a population-based study6
Trends in adjuvant therapy after breast-conserving surgery for ductal carcinoma in situ of breast: a retrospective cohort study using the National Breast Cancer Registry of Japan6
Genitourinary symptoms in women with breast cancer: what do oncology health professionals think and do about them?6
Effect of radiotherapy after breast-conserving surgery in elderly patients with early breast cancer according to the AJCC 8th Edition Breast Cancer Staging System in Japan6
Can breast MRI and adjunctive Doppler ultrasound improve the accuracy of predicting pathological complete response after neoadjuvant chemotherapy?6
BAHD1 serves as a critical regulator of breast cancer cell proliferation and invasion6
Interactions between exposure to polycyclic aromatic hydrocarbons and xenobiotic metabolism genes, and risk of breast cancer6
Rethinking screening mammography in Japan: next-generation breast cancer screening through breast awareness and supplemental ultrasonography6
Physicians’ perception about the impact of breast reconstruction on patient prognosis: a survey in Japan6
The effects of home-based exercise therapy for breast cancer-related fatigue induced by radical radiotherapy6
Hsa-miR-3651 could serve as a novel predictor for in-breast recurrence via FRMD35
Evaluation of the ability of the Clinical Treatment Score at 5 years (CTS5) compared to other risk stratification methods to predict the response to an extended endocrine therapy in breast cancer pati5
Recommendations for the management of breast cancer patients during the COVID-19 pandemic from the Japan Breast Cancer Society5
Is adjuvant chemotherapy necessary in older patients with breast cancer?5
Racial differences in predictive value of the 21-gene recurrence score assay: a population-based study using the SEER database5
Interleukin (IL)-17A in triple-negative breast cancer: a potent prognostic factor associated with intratumoral neutrophil infiltration5
Clinical outcomes and patient satisfaction with the use of biological and synthetic meshes in one-stage implant-based breast reconstruction5
Relationship between MRI findings and invasive breast cancer with podoplanin-positive cancer-associated fibroblasts5
Breast cancer screening using digital breast tomosynthesis compared to digital mammography alone for Japanese women5
PI3K/AKT/mTOR signaling pathway: an important driver and therapeutic target in triple-negative breast cancer5
Features from MRI texture analysis associated with survival outcomes in triple-negative breast cancer patients5
Breast cancer patient-reported outcome of factors influencing cosmetic satisfaction after breast-conserving therapy5
Dynamic tumor microenvironment, molecular heterogeneity, and distinct immunologic portrait of triple-negative breast cancer: an impact on classification and treatment approaches5
Impact of serum vitamin D on the response and prognosis in breast cancer patients treated with neoadjuvant chemotherapy5
Genetic medicine is accelerating in Japan5
Conservative axillary surgery is emerging in the surgical management of breast cancer5
Predictors of persistent post-surgical pain intensity and interference at 1 year after breast cancer surgery: assessing central sensitization, central sensitivity symptoms, and psychological factors5
Impact of background parenchymal enhancement levels on the diagnosis of contrast-enhanced digital mammography in evaluations of breast cancer: comparison with contrast-enhanced breast MRI5
Breast cancer-derived exosomal lncRNA SNHG14 induces normal fibroblast activation to cancer-associated fibroblasts via the EBF1/FAM171A1 axis5
Meta-analysis of nanoparticle albumin-bound paclitaxel used as neoadjuvant chemotherapy for operable breast cancer based on individual patient data (JBCRG-S01 study)5
A Japanese prospective multi-institutional feasibility study on accelerated partial breast irradiation using multicatheter interstitial brachytherapy: clinical results with a median follow-up of 60 mo5
The involvement of axillary reverse mapping nodes in patients with clinically node-negative breast cancer5
Phytochemical-conjugated bio-safe gold nanoparticles in breast cancer: a comprehensive update5
A risk scoring system based on tumor microenvironment cells to predict prognosis and immune activity in triple-negative breast cancer5
Single HER2-positive tumor cells are detected in initially HER2-negative breast carcinomas using the DEPArray™–HER2-FISH workflow5
0.043993949890137